Dulaglutide, a long-acting GLP-1 receptor agonist, can suppress copeptin levels in individuals with euvolaemia, a secondary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback